
Associated Press (12.26.06) - Thursday, December 28, 2006
Rita Beamish
The audit, conducted by the US Agency for International Development's inspector general, focused on care and prevention from 2004 to 2005 but did not highlight drug treatment. Joe Farinella, USAID's assistant inspector general who oversaw the investigations, said many grant recipients failed to provide documents that would give "reasonable assurances that what they say was done was in fact carried out." USAID is recommending the administration improve reporting methods and clarify its directives.
Ambassador Mark Dybul, the US global AIDS coordinator, said the administration has worked to fix the problems the audit revealed, in part by imposing tighter reporting systems to improve the accuracy of information. Dybul said some of the poor record keeping was due to the eagerness of program officials to get the money into the field to help patients.
"Our approach was, 'Get the services out, start moving the programs,'" said Dybul. "You could've waited for three years to get all these systems in place and an awful lot of people would have died," he said, adding that he has "extraordinary confidence" in PEPFAR's overall numbers.
The figures are important because Congress and others are closely tracking PEPFAR's strategies as it pumps unprecedented sums into AIDS-hit nations in Africa and elsewhere. "The accuracy of the numbers is essential and is something Congress should look at," said Rep. Henry Waxman (D-Calif.), the incoming chairperson of the House Government Reform Committee.
Win Brown, a data quality consultant to Dybul's office, said the current counts of people helped country-by-country are "within scientifically acceptable ranges of numbers."
"We are putting into place reporting mechanisms that have never existed," said Dybul. "Our numbers are the tightest in the world. Yes, we have problems around the margins. We've put enormous effort into them and are improving them all the time."
061228
AD062509
Copyright © 2006 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.